Higher biologically effective dose of radiotherapy is associated with improved outcomes for locally advanced non-small cell lung carcinoma treated with chemoradiation: an analysis of the Radiation Therapy Oncology Group.
about
Radiation dose effect in locally advanced non-small cell lung cancerInnovative technologies in thoracic radiation therapy for lung cancerDefinitive radiotherapy in locally advanced non-small cell lung cancer: dose and fractionationFeasibility and efficacy of helical intensity-modulated radiotherapy for stage III non-small cell lung cancer in comparison with conventionally fractionated 3D-CRTAudiovisual biofeedback improves motion prediction accuracy.A Dosimetric Comparison of Dose Escalation with Simultaneous Integrated Boost for Locally Advanced Non-Small-Cell Lung CancerClinical significance of serum soluble death receptor 5 concentration in locally advanced non-small cell lung cancer patients.Correlation of (18)F-FDG avid volumes on pre-radiation therapy and post-radiation therapy FDG PET scans in recurrent lung cancer.Inflammation-related genetic variants predict toxicity following definitive radiotherapy for lung cancerStandard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factoAudiovisual biofeedback breathing guidance for lung cancer patients receiving radiotherapy: a multi-institutional phase II randomised clinical trial.New potential for enhancing concomitant chemoradiotherapy with FDA approved concentrations of cisplatin via the photoelectric effect.(18)F-FDG avid volumes on pre-radiotherapy FDG PET as boost target delineation in non-small cell lung cancer.Defining local-regional control and its importance in locally advanced non-small cell lung carcinomaProliferation PET image to characterize pathological spatial features in patients with non-small cell lung cancer: a pilot study.Radiation Dose Escalation in Stage III Non-Small-Cell Lung Cancer.Accelerated hypofractionated three-dimensional conformal radiation therapy (3 Gy/fraction) combined with concurrent chemotherapy for patients with unresectable stage III non-small cell lung cancer: preliminary results of an early terminated phase IITreatment-Related Death during Concurrent Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized StudiesExploring spatial overlap of high-uptake regions derived from dual tracer positron emission tomography-computer tomography imaging using 18F-fluorodeoxyglucose and 18F-fluorodeoxythymidine in nonsmall cell lung cancer patients: a prospective pilot sUse a survival model to correlate single-nucleotide polymorphisms of DNA repair genes with radiation dose-response in patients with non-small cell lung cancer.How does four-dimensional computed tomography spare normal tissues in non-small cell lung cancer radiotherapy by defining internal target volume?Effect of Radiation Therapy Techniques on Outcome in N3-positive IIIB Non-small Cell Lung Cancer Treated with Concurrent ChemoradiotherapyLong-term outcomes after proton therapy, with concurrent chemotherapy, for stage II-III inoperable non-small cell lung cancer.Potential for enhancing external beam radiotherapy for lung cancer using high-Z nanoparticles administered via inhalationIDEAL-CRT: A Phase 1/2 Trial of Isotoxic Dose-Escalated Radiation Therapy and Concurrent Chemotherapy in Patients With Stage II/III Non-Small Cell Lung Cancer.Dose escalation of accelerated hypofractionated three-dimensional conformal radiotherapy (at 3 Gy/fraction) with concurrent vinorelbine and carboplatin chemotherapy in unresectable stage III non-small-cell lung cancer: a phase I trial.Moderately Escalated Hypofractionated (Chemo) Radiotherapy Delivered with Helical Intensity-Modulated Technique in Stage III Unresectable Non-Small Cell Lung Cancer.Penetration of recommended procedures for lung cancer staging and management in the United States over 10 years: a quality research in radiation oncology survey.Risk factors for locoregional recurrence in patients with resected N1 non-small cell lung cancer: a retrospective study to identify patterns of failure and implications for adjuvant radiotherapy.Pattern of failure after high-dose thoracic radiation for non-small cell lung cancer: the University of Michigan experience.Therapeutic management options for stage III non-small cell lung cancer.Pre-radiotherapy FDG PET predicts radiation pneumonitis in lung cancer.A review of clinical trials of cetuximab combined with radiotherapy for non-small cell lung cancerStereotactic radiosurgery: a "targeted" therapy for cancerThe use of proton-beam therapy in the treatment of non-small-cell lung cancer.Comparison of once and twice daily radiotherapy for limited stage small-cell lung cancer.Strategies of dose escalation in the treatment of locally advanced non-small cell lung cancer: image guidance and beyond.Intensity-Modulated Radiotherapy versus 3-Dimensional Conformal Radiotherapy Strategies for Locally Advanced Non-Small-Cell Lung Cancer.Effect of Midtreatment PET/CT-Adapted Radiation Therapy With Concurrent Chemotherapy in Patients With Locally Advanced Non-Small-Cell Lung Cancer: A Phase 2 Clinical Trial.Functional lung avoidance and response-adaptive escalation (FLARE) RT: Multimodality plan dosimetry of a precision radiation oncology strategy.
P2860
Q26823043-4054BA31-DF46-478F-BF43-0F95DC378F94Q26863239-A4F78F0A-2471-4E1E-85DB-71B7F0BD827CQ27027626-D9E9C5C9-5856-48C3-93CE-0263DEAFDED8Q29248450-90750ACD-DA66-41AA-BF17-7C649EDB3066Q30440917-D5687950-6617-4DF9-9C5B-DAF4DBC56005Q33786722-DB10B7F7-58EF-423C-AB82-66846071626EQ33967735-420D5D94-E763-495B-BC8A-2CAF45925185Q34206480-691B75FF-B261-4C68-AFFC-281CCF1D9B15Q34389016-91809765-9C6F-4A91-A5B2-CEE81A0195F7Q35568485-A6AB5E87-721B-44F2-BE79-84529C0D1B73Q35695850-605349D5-F993-4F2D-8EC0-EA48D59E8FEBQ35821336-E987A2B0-A92D-4D1B-B12D-56A3B70546B8Q35870847-90373E71-1E14-4CFA-B126-81332DBF49E7Q35911195-14DBBC7B-E9DB-455E-A7BD-48B267EBD976Q35959380-96555C34-656C-483D-811E-B3E37CCA75E3Q35971034-E4CC8C07-3FBC-4FE9-B1DF-3F3F54787CA8Q35997579-5DBDA979-C06C-4C0E-A1F1-84895DF55CAFQ36051895-2D2D46AF-CBC0-48FC-80D2-7CB694317C2EQ36153707-6C39BB59-5900-4F87-900D-8D417AC570ADQ36433810-1BDFF17B-E63C-4484-AEA5-D86BE599C09BQ36439461-CBEC731C-F2E7-4255-B7F0-2237690CBA0CQ36482508-AC8E36AD-0244-4B98-BAD1-127F0F3D54E5Q36729045-93E9E508-754D-430B-8F37-26565A84395AQ37098720-AD450C1E-2530-46CA-A9BE-CD902169226CQ37123650-3811DB8A-5E7A-4E55-A3D7-9022B57CA13FQ37152509-EE63C981-7EB9-4CEC-BD7E-34CBCAD01C48Q37317610-E708CD78-DA33-4682-A517-961108305740Q37498889-95438C19-9280-4DF9-871F-62535D1ADB6CQ37581168-55A86FA3-F068-44D7-929A-DDEAF7DDAE1CQ37600525-86CD40F3-1C22-4940-AAF1-371DC26806BBQ37642455-E1EE1FBB-9F76-4471-B113-6B0D33E8A5F9Q37716623-4D162BA6-4D48-4655-80A2-8CE380901DEBQ37975010-AB08432A-2C58-42D1-85A3-31CAAD4D7231Q38029811-19FFDF30-AEA9-4AA8-B566-2E86D02EF2F2Q38088273-FEF5A92C-82FA-414D-9114-EC8C8A635D96Q38155779-573B186A-D155-4B1D-BBE5-4AB143D7FB43Q38226816-3F7523A4-1EC7-4554-A362-1641E2AE238BQ38350598-FCF3CBAC-45F5-4D9D-B7D9-AF721DA309FBQ38376135-B4E3386A-01C5-4967-ABA6-425374E2ABDAQ38401313-52288EAC-1CA8-448E-BCF3-D4D6D5AD2A7D
P2860
Higher biologically effective dose of radiotherapy is associated with improved outcomes for locally advanced non-small cell lung carcinoma treated with chemoradiation: an analysis of the Radiation Therapy Oncology Group.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Higher biologically effective ...... iation Therapy Oncology Group.
@en
Higher biologically effective ...... iation Therapy Oncology Group.
@nl
type
label
Higher biologically effective ...... iation Therapy Oncology Group.
@en
Higher biologically effective ...... iation Therapy Oncology Group.
@nl
prefLabel
Higher biologically effective ...... iation Therapy Oncology Group.
@en
Higher biologically effective ...... iation Therapy Oncology Group.
@nl
P2093
P2860
P1476
Higher biologically effective ...... iation Therapy Oncology Group.
@en
P2093
Benjamin Movsas
Elizabeth M Gore
Kathy Albain
Kyounghwa Bae
Rebecca Paulus
Walter J Curran
William T Sause
P2860
P304
P356
10.1016/J.IJROBP.2010.09.004
P407
P577
2010-10-25T00:00:00Z